Key Takeaways
- • KKR paid €6.8 billion ($8 billion) in mid-2018 to acquire Flora Food Group, a spreads and plant-based dairy business carved out of Unilever, competing against bidders including Apollo Global Management, Blackstone, and CVC Capital Partners.
- • KKR is now exploring a sale of Flora Food Group at a valuation around $10 billion, signaling a potential exit strategy after nearly eight years of ownership under challenging market conditions.
- • The carve-out transaction exemplifies the risks inherent in private equity's "corporate carve-out" strategy—acquiring underperforming divisions from conglomerates with expectations of operational improvement and value creation, which has not materialized as anticipated.
- • Flora Food Group's portfolio includes major consumer brands: Flora, Becel, I Can't Believe It's Not Butter, and Violife (plant-based alternatives), positioning it as a global spreads and dairy alternatives platform despite recent sector headwinds.
- • The timing of the potential sale reflects broader private equity recalibration in exit strategies, particularly in the food and plant-based sectors facing margin pressure and shifting consumer preferences.
Summary
KKR is exploring a potential exit of Flora Food Group, the spreads and plant-based dairy company it acquired from Unilever in 2018, at a valuation of approximately $10 billion. The transaction represents a critical juncture for one of private equity's most high-profile corporate carve-out deals, according to reporting from the Financial Times and Reuters in late April 2026.
The original acquisition in mid-2018 valued Flora Food Group at €6.8 billion ($8 billion), making it a competitive process that attracted interest from major alternative asset managers including Apollo Global Management, Blackstone, and CVC Capital Partners. At the time, Unilever's willingness to divest the struggling spreads business sparked a bidding war among buyout firms seeking what appeared to be a turnaround opportunity in the consumer food sector.
However, KKR's experience with Flora Food Group illustrates the challenges inherent in the "corporate carve-out" strategy—the purchase of poorly performing divisions from sprawling conglomerates under the assumption that private equity operational expertise can unlock value. Bloomberg analysis notes that KKR's grim experience with this deal "should end any illusions that such deals always offer a quick buck," underscoring the operational and market headwinds the company has faced since acquisition.
Flora Food Group operates a portfolio of well-known consumer brands, including Flora margarine, Becel spreads, I Can't Believe It's Not Butter, and Violife plant-based alternatives. Despite the strength of these legacy brands, the company has contended with secular headwinds in traditional spreads consumption and intensifying competition in the plant-based segment, which has seen margin compression across the alternative protein industry over the past 18 months.
The renewed exploration of a $10 billion sale reflects KKR's recalibration of exit strategies in the food sector. At that valuation, the transaction would represent a modest return on the original $8 billion investment, particularly when factoring in eight years of operational investment and working capital requirements. The timing suggests KKR may be prioritizing liquidity and capital redeployment over maximizing returns from the asset, a strategic shift common when portfolio companies fail to meet growth and margin expectations established at acquisition.
The original acquisition in mid-2018 valued Flora Food Group at €6.8 billion ($8 billion), making it a competitive process that attracted interest from major alternative asset managers including Apollo Global Management, Blackstone, and CVC Capital Partners. At the time, Unilever's willingness to divest the struggling spreads business sparked a bidding war among buyout firms seeking what appeared to be a turnaround opportunity in the consumer food sector.
However, KKR's experience with Flora Food Group illustrates the challenges inherent in the "corporate carve-out" strategy—the purchase of poorly performing divisions from sprawling conglomerates under the assumption that private equity operational expertise can unlock value. Bloomberg analysis notes that KKR's grim experience with this deal "should end any illusions that such deals always offer a quick buck," underscoring the operational and market headwinds the company has faced since acquisition.
Flora Food Group operates a portfolio of well-known consumer brands, including Flora margarine, Becel spreads, I Can't Believe It's Not Butter, and Violife plant-based alternatives. Despite the strength of these legacy brands, the company has contended with secular headwinds in traditional spreads consumption and intensifying competition in the plant-based segment, which has seen margin compression across the alternative protein industry over the past 18 months.
The renewed exploration of a $10 billion sale reflects KKR's recalibration of exit strategies in the food sector. At that valuation, the transaction would represent a modest return on the original $8 billion investment, particularly when factoring in eight years of operational investment and working capital requirements. The timing suggests KKR may be prioritizing liquidity and capital redeployment over maximizing returns from the asset, a strategic shift common when portfolio companies fail to meet growth and margin expectations established at acquisition.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.